| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8239605 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 8 Pages |
Abstract
Use of adjuvant RT doubled after the INT-0116 trial results became public; however, the fraction of patients receiving adjuvant RT is still low. Additional examination of the statistically significant and clinically relevant variability between different SEER regions, tumor characteristics, and patient demographics is warranted.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Natalie G. M.D., M.P.H., Ulrich M.D., M.Sc., Nancy N. M.D., Ph.D., Alex Ph.D., Jolie M.D., Carol J. M.D., Ph.D., Calvin H.L. M.D., M.P.H.,